A recent study led by Tel Aviv University and Clatit, Israel’s second largest healthcare provider, found that the South African variant of SARS-CoV-2, known as B.1.351,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.